3 years.

6.4 Special precautions for storage

 This medicinal product does not require any special storage conditions.

6.5 Nature and contents of container

 The capsules are provided in carton packs. Each pack contains three Polyvinylchloride (PVC) / Polychlorotrifluoroethylene (PCTFE) / Aluminium foil blisters, each with seven capsules. This gives a total of 21 capsules per pack.

6.6 Special precautions for disposal and other handling

 Unused medicinal product should be returned to the pharmacist.

7. MARKETING AUTHORISATION HOLDER

 Celgene Europe Limited

1 Longwalk Road

Stockley Park

Uxbridge

UB11 1DB United Kingdom

8. MARKETING AUTHORISATION NUMBER(S)

 Revlimid 5 mg hard capsules
 EU/1/07/391/001
Revlimid 10 mg hard capsules
 EU/1/07/391/002
Revlimid 15 mg hard capsules
 EU/1/07/391/003
Revlimid 25 mg hard capsules
 EU/1/07/391/004

9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

 14/06/2007

10. DATE OF REVISION OF THE TEXT

 26/05/2011

Detailed information on this medicine is available on the website of the European Medicines Agency: http://www.ema.europa.eu/.